Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director/PDMR Shareholding

1st Apr 2016 15:33

RNS Number : 9552T
GlaxoSmithKline PLC
01 April 2016
 

GlaxoSmithKline plc

 

Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons

 

In accordance with Disclosure and Transparency Rule 3.1.4R(1)(a), I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares ('ADSs') of GlaxoSmithKline plc (the 'Company').

 

On 31 March 2016, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £14.05 per Ordinary Share, and notional ADSs at a price of $40.53 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 January 2016 to 31 March 2016:

 

 

Non Executive Director

Ordinary Shares

No. of ADSs

Sir Philip Hampton

3,113.879

 

Professor Sir Roy Anderson

511.566

 

Vindi Banga

1,512.456

 

Dr Stephanie Burns

678.178

 

Stacey Cartwright

378.114

 

Lynn Elsenhans

1,389.096

 

Judy Lewent

526.173

 

Sir Deryck Maughan

1,356.357

 

Dr Daniel Podolsky

1,227.736

 

Urs Rohner

467.082

 

Hans Wijers

378.114

 

Jesse Goodman was appointed to the Board with effect from 1 January 2016.

 

In accordance with the share allocation arrangements for Non-Executive Directors, 25% of Jesse Goodman's fees will be retained and will be reinvested in the Company's ADSs at a future date, to be mutually agreed.

 

The Company and the Non-Executive Directors were advised of these allocations on 1 April 2016.

 

 

V A Whyte

Company Secretary

 

1 April 2016

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSZFLFBQZFXBBB

Related Shares:

Glaxosmithkline
FTSE 100 Latest
Value8,632.33
Change89.77